Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the management of the Company shall be meeting analysts/investors through Chasing Growth Conference hosted by Kotak Securities on 20th February, 2023.
The above information is a part of company’s filings submitted to BSE.